Mastoparan B
| Internal ID | 9fa0d67e-3ace-439a-8051-ef8296257d45 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | (2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2R)-2-amino-4-methylpentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]propanoyl]amino]-N-[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]hexanamide |
| SMILES (Canonical) | CCC(C)C(C(=O)NC(C(C)C)C(=O)NC(CO)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)N)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CC(C)C)N |
| SMILES (Isomeric) | CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC(C)C)N |
| InChI | InChI=1S/C78H138N20O16/c1-14-47(12)64(98-75(111)61(41-100)94-70(106)55(29-19-23-33-81)90-73(109)58(37-44(6)7)92-69(105)54(28-18-22-32-80)88-67(103)51(83)35-42(2)3)78(114)97-63(46(10)11)77(113)95-60(40-99)74(110)93-59(38-49-39-85-52-26-16-15-25-50(49)52)72(108)86-48(13)66(102)87-53(27-17-21-31-79)68(104)89-56(30-20-24-34-82)71(107)96-62(45(8)9)76(112)91-57(65(84)101)36-43(4)5/h15-16,25-26,39,42-48,51,53-64,85,99-100H,14,17-24,27-38,40-41,79-83H2,1-13H3,(H2,84,101)(H,86,108)(H,87,102)(H,88,103)(H,89,104)(H,90,109)(H,91,112)(H,92,105)(H,93,110)(H,94,106)(H,95,113)(H,96,107)(H,97,114)(H,98,111)/t47-,48-,51+,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-/m0/s1 |
| InChI Key | NSFBOCKFBVQQKB-LTKSBDBTSA-N |
| Popularity | 18 references in papers |
| Molecular Formula | C78H138N20O16 |
| Molecular Weight | 1612.10 g/mol |
| Exact Mass | 1611.05996840 g/mol |
| Topological Polar Surface Area (TPSA) | 608.00 Ų |
| XlogP | 0.50 |
| Atomic LogP (AlogP) | -2.16 |
| H-Bond Acceptor | 21 |
| H-Bond Donor | 22 |
| Rotatable Bonds | 57 |
| 137354-65-5 |
| Mast cell degranulating peptide (vespa basalis) |
| DTXSID90160142 |
| RefChem:155966 |
| DTXCID7082633 |
| (2S)-6-amino-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S,3S)-2-(((2S)-2-(((2S)-6-amino-2-(((2S)-2-(((2S)-6-amino-2-(((2R)-2-amino-4-methylpentanoyl)amino)hexanoyl)amino)-4-methylpentanoyl)amino)hexanoyl)amino)-3-hydroxypropanoyl)amino)-3-methylpentanoyl)amino)-3-methylbutanoyl)amino)-3-hydroxypropanoyl)amino)-3-(1H-indol-3-yl)propanoyl)amino)propanoyl)amino)-N-((2S)-6-amino-1-(((2S)-1-(((2S)-1-amino-4-methyl-1-oxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-1-oxohexan-2-yl)hexanamide |
| SCHEMBL29829610 |
| DA-55246 |
| D-Leucyl-L-lysyl-L-leucyl-L-lysyl-L-seryl-L-isoleucyl-L-valyl-L-seryl-L-tryptophyl-L-alanyl-L-lysyl-L-lysyl-L-valyl-L-leucinamide |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9734 | 97.34% |
| Caco-2 | - | 0.8627 | 86.27% |
| Blood Brain Barrier | - | 0.6500 | 65.00% |
| Human oral bioavailability | - | 0.5571 | 55.71% |
| Subcellular localzation | Mitochondria | 0.3751 | 37.51% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8975 | 89.75% |
| OATP1B3 inhibitior | + | 0.9414 | 94.14% |
| MATE1 inhibitior | - | 0.7499 | 74.99% |
| OCT2 inhibitior | - | 0.8750 | 87.50% |
| BSEP inhibitior | + | 0.9639 | 96.39% |
| P-glycoprotein inhibitior | + | 0.7418 | 74.18% |
| P-glycoprotein substrate | + | 0.8769 | 87.69% |
| CYP3A4 substrate | + | 0.6950 | 69.50% |
| CYP2C9 substrate | - | 0.8075 | 80.75% |
| CYP2D6 substrate | - | 0.7692 | 76.92% |
| CYP3A4 inhibition | - | 0.8986 | 89.86% |
| CYP2C9 inhibition | - | 0.8515 | 85.15% |
| CYP2C19 inhibition | - | 0.8122 | 81.22% |
| CYP2D6 inhibition | - | 0.8864 | 88.64% |
| CYP1A2 inhibition | - | 0.7680 | 76.80% |
| CYP2C8 inhibition | + | 0.5664 | 56.64% |
| CYP inhibitory promiscuity | - | 0.8952 | 89.52% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.8400 | 84.00% |
| Carcinogenicity (trinary) | Non-required | 0.6601 | 66.01% |
| Eye corrosion | - | 0.9869 | 98.69% |
| Eye irritation | - | 0.8955 | 89.55% |
| Skin irritation | - | 0.7953 | 79.53% |
| Skin corrosion | - | 0.9350 | 93.50% |
| Ames mutagenesis | - | 0.8400 | 84.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7274 | 72.74% |
| Micronuclear | + | 0.6400 | 64.00% |
| Hepatotoxicity | - | 0.5267 | 52.67% |
| skin sensitisation | - | 0.8840 | 88.40% |
| Respiratory toxicity | + | 0.8444 | 84.44% |
| Reproductive toxicity | + | 0.9040 | 90.40% |
| Mitochondrial toxicity | + | 0.8000 | 80.00% |
| Nephrotoxicity | - | 0.6571 | 65.71% |
| Acute Oral Toxicity (c) | III | 0.6457 | 64.57% |
| Estrogen receptor binding | - | 0.4905 | 49.05% |
| Androgen receptor binding | + | 0.7057 | 70.57% |
| Thyroid receptor binding | + | 0.7446 | 74.46% |
| Glucocorticoid receptor binding | + | 0.8230 | 82.30% |
| Aromatase binding | + | 0.7839 | 78.39% |
| PPAR gamma | + | 0.7712 | 77.12% |
| Honey bee toxicity | - | 0.8319 | 83.19% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.6300 | 63.00% |
| Fish aquatic toxicity | - | 0.3958 | 39.58% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3837 | P07711 | Cathepsin L | 99.90% | 96.61% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.64% | 98.95% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 98.84% | 97.23% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.36% | 91.11% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.23% | 96.09% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 97.02% | 98.33% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 96.23% | 100.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 95.82% | 93.56% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 95.64% | 95.56% |
| CHEMBL2885 | P07451 | Carbonic anhydrase III | 95.37% | 87.45% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 93.93% | 98.05% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 93.23% | 100.00% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 93.10% | 90.20% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 92.39% | 88.56% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 92.12% | 97.21% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 91.23% | 100.00% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 90.96% | 96.28% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 90.93% | 98.89% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 90.57% | 91.81% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 90.29% | 99.17% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 90.17% | 96.00% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 89.31% | 83.10% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 88.42% | 97.64% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 88.40% | 88.42% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 88.38% | 97.09% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 88.16% | 100.00% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 87.19% | 95.56% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 86.86% | 96.95% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 86.77% | 93.18% |
| CHEMBL2535 | P11166 | Glucose transporter | 86.74% | 98.75% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 86.73% | 98.94% |
| CHEMBL3776 | Q14790 | Caspase-8 | 85.40% | 97.06% |
| CHEMBL2431 | P31751 | Serine/threonine-protein kinase AKT2 | 84.92% | 98.33% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 84.77% | 82.86% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 84.51% | 89.63% |
| CHEMBL3308 | P55212 | Caspase-6 | 83.88% | 97.56% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 83.82% | 96.47% |
| CHEMBL3155 | P34969 | Serotonin 7 (5-HT7) receptor | 83.69% | 90.71% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 83.26% | 96.90% |
| CHEMBL5028 | O14672 | ADAM10 | 83.00% | 97.50% |
| CHEMBL1287628 | Q9Y5S8 | NADPH oxidase 1 | 82.81% | 95.48% |
| CHEMBL1808 | P12821 | Angiotensin-converting enzyme | 82.80% | 93.39% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 82.72% | 98.59% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 82.32% | 90.17% |
| CHEMBL225 | P28335 | Serotonin 2c (5-HT2c) receptor | 80.70% | 89.62% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 80.50% | 92.32% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 80.02% | 93.03% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 3081833 |
| LOTUS | LTS0241197 |
| wikiData | Q105184992 |